Inventor profile of:

David K. Lyon

City:

Bend, Oregon

Country:

United States

Published Applications:

17

Last publication date:

2023-09-07

Top Assignees for applications by David K. Lyon

The entities that hold a legal rights for patent applications filed by inventor Lyon David K.:

Recent patent applications by Lyon David K.

David K. Lyon from Bend, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-07
US20230277459A1
Human necessities

PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO

#2 | 2021-07-22
US20210220277A1
Human necessities

Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

#3 | 2021-06-24
US20210186915A1
Human necessities

PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO

#4 | 2020-01-09
US20200009118A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES

#5 | 2018-04-26
US20180110760A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES

#6 | 2015-08-06
US20150218197A1
Chemistry; metallurgy

PROCESS FOR PREPARING AN ESTER OF A CELLULOSE ETHER IN THE PRESENCE OF AN ALIPHATIC CARBOXYLIC ACID

#7 | 2014-06-19
US20140171441A1
Human necessities

Pharmaceutical compositions with enhanced performance

#8 | 2014-06-12
US20140161895A1
Human necessities

Pharmaceutical compositions of dextran polymer derivatives

#9 | 2013-04-25
US20130102691A1
Human necessities

Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution

#10 | 2012-01-05
US20120003282A1
Human necessities

Pharmaceutical compositions of dextran polymer derivatives

#11 | 2011-03-01
US10739567
-

Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor

#12 | 2008-08-21
US20080199527A1
Human necessities

Enteric Coated Azithromycin Multiparticulates

#13 | 2005-08-18
US20050181062A1
Human necessities

Multiparticulate crystalline drug compositions having controlled release profiles

#14 | 2005-08-18
US20050181061A1
Human necessities

Extrusion process for forming chemically stable drug multiparticulates

#15 | 2005-07-21
US20050158391A1
Human necessities

Azithromycin multiparticulate dosage forms by melt-congeal processes

#16 | 2005-07-14
US20050152982A1
Human necessities

Controlled release multiparticulates formed with dissolution enhancers

#17 | 2005-06-09
US20050123616A1
Human necessities

Azithromycin multiparticulate dosage forms by liquid-based processes

InventorID:

211543 ⎘